+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Biobetter"

Biosimilars Market Overview, 2025-30 - Product Thumbnail Image

Biosimilars Market Overview, 2025-30

  • Report
  • May 2025
  • 102 Pages
  • Global
From
Biosimilars: Global Markets - Product Thumbnail Image

Biosimilars: Global Markets

  • Report
  • March 2025
  • 219 Pages
  • Global
From
Global Biosimilars Market 2020-2025 - Product Thumbnail Image

Global Biosimilars Market 2020-2025

  • Report
  • May 2021
  • 358 Pages
  • Global
From
The Biosimilars Landscape in Japan: 2009-2020 Study - Product Thumbnail Image

The Biosimilars Landscape in Japan: 2009-2020 Study

  • Report
  • January 2020
  • 156 Pages
  • Japan
From
Loading Indicator

Biobetter is a term used to describe biotechnology products that are designed to improve upon existing treatments or therapies. These products are typically developed through the use of genetic engineering, gene therapy, or other advanced biotechnologies. Biobetter products are designed to provide improved efficacy, safety, or convenience compared to existing treatments. The Biobetter market is a rapidly growing sector of the biotechnology industry. Companies in this market are focused on developing and commercializing products that offer improved therapeutic benefits over existing treatments. These products are often developed through the use of advanced biotechnologies such as gene therapy, gene editing, and cell therapy. Examples of companies in the Biobetter market include Moderna Therapeutics, Editas Medicine, and CRISPR Therapeutics. These companies are focused on developing and commercializing products that offer improved therapeutic benefits over existing treatments. Show Less Read more